 |
|
| NEW TRANSCRIPTION FACTORS AND THEIR ROLE IN DIABETES AND THERAPY, 5
| |
| | |
|
|
Advances in Molecular and Cellular Endocrinology
To order this title, and for more information, click here
Edited By
Jacob Friedman, University of Colorado Health Sciences Center, Denver, CO, USA
Included in series
Advances in Molecular and Cellular Endocrinology,
Description
This book contains contributions from some of the most eminent experts in the fields of genetics, biochemistry, and pathophysiology of
diabetes. Through specific examples, with broad applications, this book provides a comprehensive look at how transcription factors may
underline the pathogenetic mechanisms of diabetes and obesity.
Volume 5 provides an overview of the status of the field, while also
providing valuable information of practical utility to those who do not necessarily work in this field. The integration of basic biology with physiologically and clinically relevant proteins should provide the reader with a theoretical background to understanding the strategies
for new potential therapeutic targets and their application to disease.
Audience
Endocrinologists, Biomedical researchers, Geneticists, Molecular and Cellular Biologists
Contents
1. PPARs as therapeutic targets for treating diabetes and insulin resistance
2. Genetic regulators of human obesity and diabetes
3. NF-kb,
insulin resistance and the actions of salicylates
4. Wnt signaling and C/EBPs role in adipogenesis
5. Regulation of hepatic gluconeogenesis
C/EPBs
6. Forkhead proteins and regulation of hepatic gene expression
7. Control of mitochondrial biogenesis through PGC-1
8. Regulation
of PGC-1 in humans in insulin resistance and diabetes: Functional implications
9. FOXC2 controls resistance to obesity and Type II diabetes
10. SREB-1C regulation of nutrient homeostasis and lipid accumulation
11. GATA proteins as molecular gatekeeprs of the adipocyte
12.
Diabetes regulation of gene expression by CREB
13. Molecular etiologies of MODY and other early-onset forms of diabetes
14. Liver X receptors
as potential drug targets for Diabetes and its disorders
15. The potential therapeutic use of PPAR beta/delta agonists in lipid and glucose
homeostasis
16. Influences of new PPAR insulin sensitizers on the metabolic syndrome in Rhesus Monkeys
17. PPARgamma and metabolism:
Insights from the study of human genetic variants
| Bibliographic details |
Hardbound, 332 pages, publication date: AUG-2006
ISBN-13: 978-0-444-51158-4
ISBN-10: 0-444-51158-X
Imprint: ELSEVIER
|
| Price and Ordering |
Price:
GBP 84.99
USD 139.95
EUR 99.95
|  |
Books and book related electronic products are priced in US dollars (USD), euro (EUR), and Great Britain Pounds (GBP). USD prices apply to the Americas and Asia Pacific. EUR prices apply in Europe and the Middle East. GBP prices apply to the UK and all other countries.
|
See also information about conditions of sale & ordering procedures, and links to our regional sales offices.
|
090/925
Last update: 3 Oct 2009
|
|
| |
| | |
|
|
| |
Home | Elsevier Sites | Privacy Policy | Terms and Conditions | Feedback | Site Map | A Reed Elsevier Company